Preparation of rosiglitazone maleate sustained-release floating microspheres for improved bioavailability

Pharmazie

Volumn 65, Issue 7, 2010, Pages 477-480

  Hu, Lian Dong ^a   Xing, Qian Bin ^a   Shang, Chuang ^a   Liu, Wei ^a   Liu, Ci ^a   Luo, Zhao Liang ^a   Xu, Hong Xin ^a  

^a HEBEI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYL CELLULOSE; MICROSPHERE; OCTADECANOL; ROSIGLITAZONE; SOLVENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; DIFFUSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; EMULSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MORPHOLOGY; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE PREPARATION; TABLET; VOLUNTEER;

ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; GASTRIC EMPTYING; HALF-LIFE; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; MALE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; THIAZOLIDINEDIONES; YOUNG ADULT;

EID: 77955344266     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9828     Document Type: Article

References (15)

1. Agrawal A, Sautter MC, Jones MP (2003) Effects of rosiglitazone maleate when added to a sulfonylurea regimen in patients with type 2 diabetes mellitus and mild to moderate renal impairment: a post hoc analysis. Clin Ther 25: 2754-2764. (Pubitemid 37510588)
2. Chapelsky MC, Thompson-Culkin K, Miller AK (2003) Effect of renal impairment on the pharmacokinetics of Rosiglitazone in patients with varying degrees of renal insufficiency. J Clin Pharmacol 43: 252-259.
3. Ding LX (2000) The development and clinical experience of insulin sensitizers. World Pharm 21: 93-96.
4. Elbrecht A, Chen Y, Cullinan CA Hayes N, Leibowitz M, Moller DE, Berger J (1996) Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem Biophys Res Commun 224: 431-437. (Pubitemid 26268204)
5. El-Gibaly I (2002) Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int J Pharm 249: 7-21.
6. El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF (2001) Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm 220: 13-21.
7. Joseph NJ, Lakshmi S, Jayakrishnan A (2002) A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J Control Release 79: 71-79.
8. Kamila MM, Mondal N, Ghosh LK, Guptal BK (2009) Multiunit floating drug delivery system of rosiglitazone maleate: development, characterization, statistical optimization of drug release and in vivo evaluation. AAPS Pharm SciTech 10: 887-899.
9. Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y (1991) Preparation of multiple unit hollow microspheres (microballoons) with acrylic resins containing tranilast and their drug release characteristics (in vivo). J Control Release 16: 279-290.
10. Ma NN, Xu L, Wang QF, Zhang XR, Zhang WJ, Li Y, Jin LY, Li SM (2008) Development and evaluation of new sustained-release floating microspheres. Int J Pharm 358: 82-90.
11. Patel J, Anderson RJ, Rappaport EB (1999) Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: A twelve-week, randomised, placebocontrolled study. Diabetes Obes Metab 1: 165-172.
12. Rao MR, Borate SG, Thanki KC, Ranpise AA, Parikh GN (2009) Development and in vitro evaluation of floating Rosiglitazone maleate microspheres. Drug Dev Ind Pharm 35: 834-842.
13. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H (2004) In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 57: 235-243.
14. Singh BN, Kim KH (2000) Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release 63: 235-259.
15. Zhao SY (1999) Progress in research on healing diabetes mellitus. World Pharm 20: 130-135.